Mithridion Lands $1,250,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    505 Science Drive Madison, WI 537121
  • Company Description
    Mithridion is a biopharmaceutical company that discovers and develops drugs for neurodegenerative diseases, with a focus on Alzheimer’s disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Mithridion intends to develop its drug candidates for AD and schizophrenia in partnership with pharmaceutical or biopharmaceutical companies with the technical, manufacturing and commercial resources to address these major market opportunities.
  • M&A Terms
  • Venture Investor
    Venture Investors
  • Venture Investor
    Rocket Ventures

Trending on Xconomy